Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 4Phase 2 3Phase 4 1Phase 1 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 17NETWORK 11NIH 7INDUSTRY 4OTHER_GOV 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4

Conditions

Uterine Cervical Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Locally Advanced Cervical Cancer 1Endometrial Neoplasms 1

Interventions

Carboplatin 315Paclitaxel 303Cisplatin 250Docetaxel 238pembrolizumab 230Gemcitabine 214Pemetrexed 158Capecitabine 147Rituximab 144Bevacizumab 142Dexamethasone 125Fluorouracil 121Cyclophosphamide 102Trastuzumab 100Doxorubicin 96Nivolumab 93Prednisone 92Oxaliplatin 90atezolizumab 75Leucovorin 72durvalumab 69130-nm albumin-bound paclitaxel 68Injections 66Lenalidomide 63Irinotecan 62Bortezomib 56Letrozole 54Topotecan 53Fulvestrant 53Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × INDUSTRY × Brachytherapy × Clear all
NCT04634877 2026-06-05

KEYNOTE-B21

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
990 enrolled
Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT04221945 2026-02-20

KEYNOTE-A18

Merck Sharp & Dohme LLC

Phase 3 Completed
1,060 enrolled 30 charts 1 FDA
Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT03830866 2024-07-26

CALLA

AstraZeneca

Phase 3 Completed
770 enrolled 12 charts
Gynecologic

Locally Advanced Cervical Cancer

NCT00191100 2009-08-11

Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix

Eli Lilly and Company

Phase 3 Completed
515 enrolled 20 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡